Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RIDA pseudogene 2 (RIDAP2) is classified as a pseudogene, implying it does not code for a functional protein. Pseudogenes are genomic segments similar in sequence to known genes, but generally lack the ability to produce functional proteins due to critical mutations or lack of necessary regulatory elements[6]. Some pseudogenes can influence gene regulation, but there is no evidence that RIDAP2 has an established biological function, role in disease, or value as a therapeutic target. Information pertaining to its active gene counterpart (RIDA) describes a protein involved in hydrolytic deamination of reactive intermediates in metabolism, but this does not apply to the pseudogene itself[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RIDA pseudogene 2 (RIDAP2).